|
US6586617B1
(en)
|
1999-04-28 |
2003-07-01 |
Sumitomo Chemical Takeda Agro Company, Limited |
Sulfonamide derivatives
|
|
JP2001026506A
(ja)
*
|
1999-04-28 |
2001-01-30 |
Takeda Chem Ind Ltd |
スルホンアミド誘導体
|
|
US6503949B1
(en)
*
|
1999-05-17 |
2003-01-07 |
Noro Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
AU1401902A
(en)
|
2000-10-17 |
2002-04-29 |
Applied Research Systems |
Pharmaceutically active sulfanilide derivatives
|
|
US6657070B2
(en)
|
2000-12-13 |
2003-12-02 |
Wyeth |
Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
|
|
JP2004517892A
(ja)
|
2000-12-13 |
2004-06-17 |
ワイス |
β−アミロイド産生の複素環スルホンアミド阻害剤
|
|
GB0108592D0
(en)
|
2001-04-05 |
2001-05-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB0108591D0
(en)
|
2001-04-05 |
2001-05-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2002089800A2
(en)
*
|
2001-05-05 |
2002-11-14 |
Smithkline Beecham P.L.C. |
N-aroyl cyclic amine derivatives as orexin receptor antagonists
|
|
GB0115862D0
(en)
*
|
2001-06-28 |
2001-08-22 |
Smithkline Beecham Plc |
Compounds
|
|
US7122675B2
(en)
|
2001-08-03 |
2006-10-17 |
Schering Corporation |
Gamma secretase inhibitors
|
|
AR034390A1
(es)
|
2001-08-03 |
2004-02-25 |
Schering Corp |
Derivados de 1-sulfonil-tetrahidro quinolinas sustituidas, composiciones farmaceuticas y el uso de las mismas para la elaboracion de medicamentos como inhibidores de la gama secretasa
|
|
GB0120347D0
(en)
|
2001-08-21 |
2001-10-17 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CA2471099C
(en)
|
2001-12-20 |
2011-04-12 |
Bristol-Myers Squibb Company |
.alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors
|
|
PE20030701A1
(es)
|
2001-12-20 |
2003-08-21 |
Schering Corp |
Compuestos para el tratamiento de trastornos inflamatorios
|
|
KR100927304B1
(ko)
|
2001-12-27 |
2009-11-18 |
다이이찌 세이야꾸 가부시기가이샤 |
β-아밀로이드 단백 생산·분비 저해제
|
|
DE10201392A1
(de)
*
|
2002-01-16 |
2003-07-31 |
Bayer Ag |
Phenylsulfoxide und-sulfone
|
|
KR20050010882A
(ko)
*
|
2002-06-11 |
2005-01-28 |
와이어쓰 |
베타 아밀로이드 생산의 치환 페닐술폰아미드 저해제
|
|
US6989399B2
(en)
|
2002-08-01 |
2006-01-24 |
Bristol-Myers Squibb Company |
Antiamyloid phenylsulfonamides: N-alkanol derivatives
|
|
GB0223040D0
(en)
|
2002-10-04 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
GB0223039D0
(en)
|
2002-10-04 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
GB0223038D0
(en)
|
2002-10-04 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
RU2334735C2
(ru)
|
2002-10-11 |
2008-09-27 |
Актелион Фармасьютиклз Лтд. |
Производные сульфониламиноуксусной кислоты и их применение в качестве антагонистов рецепторов орексина
|
|
US7521481B2
(en)
|
2003-02-27 |
2009-04-21 |
Mclaurin Joanne |
Methods of preventing, treating and diagnosing disorders of protein aggregation
|
|
WO2004080952A1
(de)
*
|
2003-03-10 |
2004-09-23 |
Bayer Healthcare Ag |
Phenylsulfonamid-derivate zur behandlung der alzheimerschen krankheit
|
|
KR20060002908A
(ko)
|
2003-03-31 |
2006-01-09 |
와이어쓰 |
베타 아밀로이드 생산 억제제인 플루오로- 및트리플루오로알킬-함유 헤테로사이클릭 설폰아미드 및 이의유도체
|
|
EA200501607A1
(ru)
*
|
2003-04-14 |
2006-06-30 |
ДЗЕ ИНСТИТЬЮТС ФОР ФАРМАСЬЮТИКАЛ ДИСКАВЕРИ, ЭлЭлСи |
Замещённые фенилалкановые кислоты
|
|
WO2004101562A2
(en)
|
2003-05-13 |
2004-11-25 |
Schering Corporation |
Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
|
|
MXPA05012323A
(es)
|
2003-05-16 |
2006-01-30 |
Merck Sharp & Dohme |
Sulfonamidas ciclicas para la inhibicion de gama-secretasa.
|
|
EP1644325A2
(en)
*
|
2003-06-23 |
2006-04-12 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
|
PL379466A1
(pl)
|
2003-06-30 |
2006-09-18 |
Daiichi Sankyo Company , Limited |
Heterocykliczne pochodne metylosulfonu
|
|
WO2005016876A2
(en)
|
2003-08-08 |
2005-02-24 |
Schering Corporation |
Cyclic amine bace-1 inhibitors having a benzamide substituent
|
|
AR045219A1
(es)
|
2003-08-08 |
2005-10-19 |
Pharmacopeia Inc |
Aminas ciclicas inhibidoras de base - 1 que poseen un sustiuyente heterociclico
|
|
GB0323258D0
(en)
|
2003-10-04 |
2003-11-05 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
CA2544350A1
(en)
*
|
2003-10-29 |
2005-05-12 |
Elan Pharmaceuticals, Inc. |
N-substituted benzene sulfonamides
|
|
DE602005016775D1
(de)
|
2004-01-16 |
2009-11-05 |
Wyeth Corp |
Heterocyclische, ein azol enthaltende sulfonamidinhibitoren der beta-amyloid-produktion
|
|
US8193389B2
(en)
|
2004-03-11 |
2012-06-05 |
Elan Pharmaceuticals, Inc. |
N-substituted benzene sulfonamides
|
|
US7423147B2
(en)
|
2004-03-31 |
2008-09-09 |
Janssen Pharmaceutical, N.V. |
Pyridine compounds as histamine H3 modulators
|
|
RU2361872C2
(ru)
|
2004-05-26 |
2009-07-20 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Циннамидное соединение
|
|
PE20060481A1
(es)
|
2004-06-30 |
2006-06-19 |
Schering Corp |
N-arilsulfonilaminas heterociclicas sustituidas como inhibidores de gamma-secretasas
|
|
CA2574218A1
(en)
|
2004-07-22 |
2006-02-09 |
Schering Corporation |
Substituted amide beta secretase inhibitors
|
|
DE602005019602D1
(de)
|
2004-10-26 |
2010-04-08 |
Eisai R&D Man Co Ltd |
Amorphe form einer zimtsäureamidverbindung
|
|
EP1805136A1
(en)
*
|
2004-10-28 |
2007-07-11 |
The Institutes for Pharmaceutical Discovery, LLC |
Substituted phenylalkanoic acids
|
|
US7569562B2
(en)
|
2005-01-18 |
2009-08-04 |
Elan Pharmaceuticals, Inc. |
N-substituted heterocyclic sulfonamides
|
|
CA2595994A1
(en)
*
|
2005-01-27 |
2006-08-03 |
Alma Mater Studiorum - Universita' Di Bologna |
Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
|
|
AU2006234441B2
(en)
*
|
2005-04-08 |
2011-07-07 |
Daiichi Sankyo Company, Limited |
Pyridylmethylsulfone derivative
|
|
TWI370130B
(en)
|
2005-11-24 |
2012-08-11 |
Eisai R&D Man Co Ltd |
Two cyclic cinnamide compound
|
|
KR20080069221A
(ko)
|
2005-11-24 |
2008-07-25 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
모르폴린 타입의 신나미드 화합물
|
|
CN102702044A
(zh)
|
2006-01-20 |
2012-10-03 |
先灵公司 |
作为γ分泌酶抑制剂的碳环和杂环芳基砜化合物
|
|
CA2641555A1
(en)
*
|
2006-02-06 |
2007-08-16 |
Elan Pharmaceuticals, Inc. |
Preferential inhibition of presenilin-1
|
|
WO2011053822A2
(en)
|
2009-11-01 |
2011-05-05 |
The Brigham And Women's Hospital, Inc. |
Notch inhibition in the treatment and prevention of obesity and metabolic syndrome
|
|
WO2007103114A2
(en)
|
2006-03-07 |
2007-09-13 |
The Brigham & Women's Hospital, Inc. |
Notch inhibition in the treatment or prevention of atherosclerosis
|
|
US9567396B2
(en)
|
2006-03-07 |
2017-02-14 |
Evonik Degussa Gmbh |
Notch inhibition in the prevention of vein graft failure
|
|
TWI378091B
(en)
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
|
EP2007717A1
(en)
|
2006-04-11 |
2008-12-31 |
Actelion Pharmaceuticals Ltd. |
Novel sulfonamide compounds
|
|
WO2007143422A2
(en)
|
2006-05-30 |
2007-12-13 |
Janssen Pharmaceutica N.V. |
Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
|
|
US7737141B2
(en)
|
2006-07-28 |
2010-06-15 |
Eisai R&D Management Co., Ltd. |
Prodrug of cinnamide compound
|
|
TW200817319A
(en)
|
2006-08-10 |
2008-04-16 |
Astellas Pharma Inc |
Sulfonamide compound or salt thereof
|
|
WO2008061247A2
(en)
*
|
2006-11-16 |
2008-05-22 |
The Regent Of The University Of California |
Benzenesulfonanilide compound inhibitors of urea transporters
|
|
CA2676715A1
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of ad and related conditions
|
|
WO2009008980A2
(en)
|
2007-07-05 |
2009-01-15 |
Schering Corporation |
Tetrahydropyranochromene gamma secretase inhibitors
|
|
EP2178882B1
(en)
|
2007-07-17 |
2013-04-17 |
Merck Sharp & Dohme Corp. |
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
|
|
US7935815B2
(en)
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
|
BRPI0815773A2
(pt)
|
2007-08-31 |
2019-09-24 |
Eisai R&D Man Co Ltd |
composto, e, medicamento.
|
|
TW200920362A
(en)
|
2007-09-11 |
2009-05-16 |
Daiichi Sankyo Co Ltd |
Alkylsulfone derivatives
|
|
US8084477B2
(en)
*
|
2007-10-31 |
2011-12-27 |
Bristol-Myers Squibb Company |
Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
|
|
US8093276B2
(en)
|
2007-10-31 |
2012-01-10 |
Bristol-Myers Squibb Company |
Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
|
|
CN101868454A
(zh)
|
2007-11-20 |
2010-10-20 |
詹森药业有限公司 |
作为组胺h3受体调节剂的环烷基氧基吡啶化合物和杂环烷基氧基吡啶化合物
|
|
EP2222636B1
(en)
|
2007-12-21 |
2013-04-10 |
Ligand Pharmaceuticals Inc. |
Selective androgen receptor modulators (sarms) and uses thereof
|
|
WO2009120783A1
(en)
*
|
2008-03-25 |
2009-10-01 |
The Johns Hopkins University |
High affinity inhibitors of hepatitis c virus ns3/4a protease
|
|
EP2291181B9
(en)
|
2008-04-18 |
2013-09-11 |
University College Dublin National University Of Ireland, Dublin |
Captodiamine for the treatment of depression symptoms
|
|
WO2009137657A1
(en)
*
|
2008-05-08 |
2009-11-12 |
Bristol-Myers Squibb Company |
2-aryl glycinamide derivatives
|
|
GB0812969D0
(en)
|
2008-07-15 |
2008-08-20 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
TW201020247A
(en)
*
|
2008-11-06 |
2010-06-01 |
Gruenenthal Gmbh |
Substituierte disulfonamide
|
|
US8044077B2
(en)
|
2009-03-19 |
2011-10-25 |
Bristol-Myers Squibb Company |
Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production
|
|
US7977362B2
(en)
|
2009-03-20 |
2011-07-12 |
Bristol-Myers Squibb Company |
Alpha-(N-benzenesulfonamido)cycloalkyl derivatives
|
|
US8252821B2
(en)
|
2009-04-14 |
2012-08-28 |
Bristol-Myers Squibb Company |
Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound
|
|
US8399465B2
(en)
|
2009-05-14 |
2013-03-19 |
Janssen Pharmaceutica Nv |
Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene A4 hydrolase
|
|
CN103193691B
(zh)
*
|
2012-01-06 |
2017-08-25 |
中国科学院上海药物研究所 |
磺胺类化合物、药物组合物及其制法和应用
|
|
BR112014021498A2
(pt)
*
|
2012-02-29 |
2017-07-18 |
Institute For Hepatitis And Virus Res |
composto, composição e método para tratar uma doença associada com formação de dna circular covalentemente fechado
|
|
US9688715B2
(en)
|
2012-06-22 |
2017-06-27 |
Temple University—Of the Commonwealth System of Higher Education |
Synthetic pGpG analogs, methods of preparation and methods of use
|
|
EP2900642B1
(en)
*
|
2012-09-27 |
2018-02-28 |
F. Hoffmann-La Roche AG |
Substituted sulfonamide compounds
|
|
EP2981522A4
(en)
|
2013-04-05 |
2016-08-31 |
Salk Inst For Biological Studi |
PPAR AGONISTS
|
|
US10441567B2
(en)
|
2014-01-17 |
2019-10-15 |
Ligand Pharmaceuticals Incorporated |
Methods and compositions for modulating hormone levels
|
|
EP2932966A1
(en)
|
2014-04-16 |
2015-10-21 |
Novartis AG |
Gamma secretase inhibitors for treating respiratory diseases
|
|
CN104151277A
(zh)
*
|
2014-06-30 |
2014-11-19 |
北京万全德众医药生物技术有限公司 |
盐酸决奈达隆一种氧化杂质的制备方法
|
|
WO2016057322A1
(en)
|
2014-10-08 |
2016-04-14 |
Salk Institute For Biological Studies |
Ppar agonists and methods of use thereof
|
|
CA2969756A1
(en)
*
|
2014-12-05 |
2016-06-09 |
Aquinnah Pharmaceuticals, Inc. |
Sulfonamide derivatives, compositions and methods of use in the treatment of neurodegenerative diseases
|
|
CN106466313A
(zh)
*
|
2015-08-18 |
2017-03-01 |
中国科学院上海药物研究所 |
一类磺酰胺基取代的酰胺类衍生物在制备用于治疗阿尔茨海默病的药物中的用途
|
|
EA037371B1
(ru)
|
2015-10-07 |
2021-03-19 |
Митобридж, Инк. |
Агонисты ppar, соединения, фармацевтические композиции и способы их применения
|
|
US11358954B2
(en)
|
2016-04-13 |
2022-06-14 |
Mitobridge, Inc. |
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
|
|
TWI754702B
(zh)
*
|
2016-12-28 |
2022-02-11 |
德商Ｕｃｂ製藥有限公司 |
（氮雜）吲哚－和苯並呋喃－３－磺醯胺類
|
|
TW202406538A
(zh)
|
2018-01-10 |
2024-02-16 |
美商克拉治療有限責任公司 |
包含苯基磺醯胺之醫藥組合物及其治療應用
|
|
US12485126B2
(en)
|
2018-07-19 |
2025-12-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Combination for treating cancer
|
|
WO2020214834A1
(en)
|
2019-04-19 |
2020-10-22 |
Ligand Pharmaceuticals Inc. |
Crystalline forms and methods of producing crystalline forms of a compound
|
|
US20220274921A1
(en)
*
|
2019-07-11 |
2022-09-01 |
Cura Therapeutics, Llc |
Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
|
CN112457687B
(zh)
*
|
2019-09-06 |
2022-10-25 |
台湾永光化学工业股份有限公司 |
新颖反应性染料
|
|
US20230416830A1
(en)
|
2020-11-16 |
2023-12-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for predicting and treating uveal melanoma
|